ZetrOZ Systems Revolutionizes Sports Injury Treatment with Targeted Ultrasound Technology
The sam® wearable ultrasound device is designed to accelerate soft tissue healing, reducing reliance on surgery or pain medication for common sports injuries.
TRUMBULL, Conn. (FreePR.org) -- As sports seasons kick off, ZetrOZ Systems, pioneers of sustained acoustic medicine and creators of the sam® wearable ultrasound technology, share expert insights on optimizing device placement to maximize therapeutic outcomes for common athletic injuries.
The innovative sam® device, protected by 48 patents and developed with backing from the National Institutes of Health, U.S. Department of Defense, and National Science Foundation, is engineered to treat injuries in the back, as well as upper and lower extremities.
“Our mission at ZetrOZ Systems is to continually advance medical treatment possibilities,” said Dr. George Lewis, founder and CEO. “By fine-tuning device placement techniques, we empower athletes and healthcare providers to achieve better recovery outcomes and reduce downtime from painful injuries.”
Innovative Design for Precise Healing
The sam® device’s convex applicator head is specifically designed to deliver therapeutic ultrasound waves into a targeted area about the size of a grapefruit. This advanced design ensures deeper tissue penetration, enhanced blood flow, and accelerated healing.
Targeted Placement for Maximum Effectiveness
Back Injuries: The sam® device can be equipped with dual applicators for focused bilateral or unilateral treatment of soft tissue injuries along the spine. This ensures ultrasound waves reach the precise areas requiring healing.
Upper Extremities: Athletes prone to repetitive motion injuries, such as baseball players, can benefit from tailored placement for shoulders and elbows. Dual applicators can be positioned on both the front and back of the shoulder, while elbow injuries are addressed with lateral or interior/exterior placement based on the affected region.
Lower Extremities: High-impact sports like soccer and football often lead to injuries in the legs, knees, or ankles. The device’s flexible placement accommodates treatment on either side of these areas, delivering targeted therapy to the damaged tissues for optimal recovery.
These customizable placement techniques allow for patient-specific treatments, ensuring maximum efficacy in promoting healing and reducing recovery times. The effectiveness of the sam® device has been validated in 42 peer-reviewed publications and 20 clinical studies across various injury types.
About ZetrOZ Systems
ZetrOZ Systems is at the forefront of innovation in sports medicine, specializing in wearable bioelectronic devices that deliver sustained acoustic medicine (sam®). Supported by extensive research and federal funding, ZetrOZ holds 46 proprietary patents and is the sole manufacturer of the sam® product line, engineered to treat both acute and chronic musculoskeletal conditions.
For additional information, visit https://samrecover.com.
###
Sponsor Message
Millions of Americans turn to Canadian pharmacies for affordable access to essential medications like Lipitor and Crestor for managing cholesterol, or Nexium for acid reflux and GERD relief. Insulin options such as Humalog and Lantus are key for diabetes care, while Advair Diskus and Ventolin inhalers help manage chronic respiratory conditions. Mental health treatments like Zoloft, Prozac, and Abilify offer essential support for individuals coping with depression, anxiety, or bipolar disorder, while medications such as Eliquis, Plavix, and Xarelto play a vital role in stroke prevention and heart health. Popular therapies for pain management, such as Celebrex, and for thyroid health, like Synthroid, are frequently ordered. Moreover, erectile dysfunction can be treated with medications like Viagra and Cialis, while Januvia supports Type 2 diabetes management. For those impacted by narcolepsy or excessive daytime sleepiness, Provigil and Nuvigil are indispensable. Canadian pharmacies offer vital medications like Cymbalta for nerve pain and Aricept for Alzheimer's, ensuring affordable access for U.S. patients.
